⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Alvin ChangM.D.

Internal Medicine · Tustin, CA 92780

NPI: 1396857181

Share:

29

🟡 Moderate

Risk Flags

Elevated long-acting opioid rateHigh antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriberHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

25,290

Total Claims

$3.3M

Drug Cost

1,183

Beneficiaries

$2,776

Cost/Patient

Risk Score Breakdown 29/100

Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
Opioid + benzodiazepine combo+8
Long-acting opioid rate+4
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

-54%

Opioid rate vs peers

1.0% vs 2.2% avg

+97%

Cost per patient vs peers

$2,776 vs $1,411 avg

+54%

Brand preference vs peers

16.4% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.0%

Opioid Rate

258

Opioid Claims

$7,063

Opioid Cost

17.4%

Long-Acting Rate

Brand vs Generic

84% generic

Brand: 4,085 claims · $2.6M

Generic: 20,869 claims · $723K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Empagliflozin324$282K
Teriparatide63$274K
Valbenazine Tosylate34$201K
Romosozumab-Aqqg74$183K
Dapagliflozin Propanediol274$170K
Dulaglutide151$161K
Apixaban331$160K
Denosumab83$136K
Metformin Hcl43$88K
Icosapent Ethyl152$79K
Mirabegron122$63K
Paliperidone Palmitate18$62K
Sitagliptin Phosphate103$47K
Insulin Glargine,hum.Rec.Anlog119$42K
Tenofovir Alafenamide26$39K

Prescribing Profile

256

Unique Drugs

$710K

IRA Negotiated Drugs

$189K

GLP-1 Drugs

29.0

Anomaly Score

Patient Profile

77

Avg Age

56%

Female

1.56

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data